Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Iscience|April 20, 2026
VE-cadherin interaction proteomics identifies ARVCF as stabilizer of endothelial adherens junctionsRianne M Schoon, Tsveta S van Krimpen-Malinova, Iris de Heer, et al.
Blood|February 5, 2021
N-glycan-mediated shielding of ADAMTS13 prevents binding of pathogenic autoantibodies in immune-mediated TTPBogac Ercig, Nuno A G Graça, Kadri Kangro, et al.
Blood Advances|January 4, 2018
The class I scavenger receptor CD163 promotes internalization of ADAMTS13 by macrophagesFabian C Verbij, Nicoletta Sorvillo, Paul H P Kaijen, et al.
Journal of Thrombosis and Haemostasis : JTH|January 26, 2023
Proteomic landscapes of inherited platelet disorders with different etiologiesIris C Kreft, Elise J Huisman, Marjon H Cnossen, et al.
British Journal of Clinical Pharmacology|February 10, 2019
Effects of prednisone on docetaxel pharmacokinetics in men with metastatic prostate cancer: A randomized drug-drug interaction studyBodine P S Belderbos, Koen G A M Hussaarts, Leonie J van Harten, et al.
International Journal of Molecular Sciences|February 7, 2020
The RNA-Binding Protein ATXN2 is Expressed during Megakaryopoiesis and May Control Timing of Gene ExpressionMarten Hansen, Sabrina Zeddies, Marjolein Meinders, et al.
Breast Care (Basel, Switzerland)|January 28, 2022
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01)Annelot G J van Rossum, Ingrid A M Mandjes, Erik van Werkhoven, et al.
Molecular Biology of the Cell|December 24, 2025
The RhoGEF Trio regulates the formation of tensile linear endothelial junctions to improve barrier functionJos van Rijssel, Thijs J Sluiter, Jeffrey M A van der Krogt, et al.
Pageof 19